AUSTIN, Texas (AP) — AUSTIN, Texas (AP) — Lumos Pharma, Inc. (LUMO) on Thursday reported a loss of $7.5 million in its third quarter.

The Austin, Texas-based company said it had a loss of 90 cents per share.

The biopharmaceutical company posted revenue of $726,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LUMO at https://www.zacks.com/ap/LUMO